Home > Chemicals & Materials > Polymers > Industrial Polymers > Medical Styrenic Block Copolymers Market

Medical Styrenic Block Copolymers Market Share

Report ID: GMI5102
Published Date: Dec 2024
Report Format: PDF

Download Free Sample

Medical Styrenic Block Copolymers Market Share

Medical Styrenic Block Copolymers Market Company Share, (2024)

Asahi Kasei is a leading innovator in the polymer industry, producing high-performance SBCs for medical applications. Their focus on biocompatible and sterilizable materials supports advancements in medical devices like tubing and flexible films. Dynasol specializes in manufacturing synthetic rubber and SBCs, offering products tailored for healthcare applications. Their materials provide durability and flexibility, making them ideal for medical packaging and disposable devices.

INEOS Styrolution is a prominent player in the SBC market, delivering medical-grade solutions with excellent clarity and strength. Their SBCs are widely used in IV bags and drug delivery systems, addressing the industry's high-performance demands.

JSR Corporation develops advanced elastomers, including SBCs, to meet the stringent requirements of medical applications. Their products ensure high precision and reliability in medical tubing and other critical healthcare components. Kraton is renowned for its innovation in styrenic block copolymers, focusing on healthcare solutions that prioritize safety and performance. Their SBCs find applications in wound care, medical films, and flexible medical devices.

Medical Styrenic Block Copolymers Market Companies

Major players operating in the medical styrenic block copolymers industry are:

Asahi Kasei
Dynasol
INEOS Styrolution
JSR Corporation
Kraton
Kumho Petrochemical
LG Chem
RTP Company
TSRC
Zeon

Authors: Kiran Pulidindi, Keshav Tandle

Frequently Asked Questions (FAQ) :

The global market size for medical styrenic block copolymers was valued at USD 728.8 million in 2024 and is projected to reach USD 1.4 billion by 2034, driven by a CAGR of over 6.6% during the forecast period, supported by increasing demand for medical-grade materials.

Styrene butadiene styrene (SBS) accounted for USD 288.6 million in revenue in 2024, dominating the product segment due to its exceptional elasticity, strength, and compatibility with sterilization processes.

The U.S. market was valued at USD 274.7 million in 2024, driven by advanced healthcare infrastructure, high healthcare expenditure, and innovation in medical device manufacturing.

Major players in the industry include Asahi Kasei, Dynasol, INEOS Styrolution, JSR Corporation, Kraton, Kumho Petrochemical, LG Chem, RTP Company, TSRC, and Zeon.